The Phase 1b trial showed improvements in FEV1 in the four adults with cystic fibrosis after two inhaled administrations. No bronchospasm or febrile reactions were observed. Get access to the ...
Sept 23 (Reuters) - Biotech company Arcturus Therapeutics (ARCT.O), opens new tab sued AbbVie (ABBV.N), opens new tab in California federal court on Tuesday for allegedly stealing trade secrets ...
A new COVID variant Arcturus has caused a huge uptick in infections in India. (Reuters) Five people in England have died from the new COVID variant dubbed Arcturus, the UK Health Security Agency ...
Arcturus Therapeutics (ARCT) shares soared 8.7% in the last trading session to close at $19.62. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...
Arcturus Therapeutics Holdings Inc. ARCT is engaged in developing messenger RNA (mRNA) medicines and vaccines based on its innovative and enabling technologies. San Diego, CA-based Arcturus has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback